- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Foot and Mouth Disease (FMD) Vaccines market will register a 10.0% CAGR in terms of revenue, the global market size will reach $ 1252.2 million by 2025, from $ 856.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Foot and Mouth Disease (FMD) Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Foot and Mouth Disease (FMD) Vaccines market by type, application, key manufacturers and key regions and countries.
This study considers the Foot and Mouth Disease (FMD) Vaccines value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Emergency Vaccines
Conventional Vaccines
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Cattle
Pig
Sheep & Goat
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Jinyu Group
MSD Animal Health
Cavet Bio
Tecon Group
CAHIC
Indian Immunologicals
BIGVET Biotech
Shen Lian
Boehringer Ingelheim
Biogenesis Bagó
Sanofi (Merial)
BVI
VETAL
CEVA
Brilliant Bio Pharma
Bayer HealthCare
ME VAC
VECOL
FGBI
LIMOR
Agrovet
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Foot and Mouth Disease (FMD) Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Foot and Mouth Disease (FMD) Vaccines market by identifying its various subsegments.
Focuses on the key global Foot and Mouth Disease (FMD) Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Foot and Mouth Disease (FMD) Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Foot and Mouth Disease (FMD) Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Foot and Mouth Disease (FMD) Vaccines Consumption 2015-2025
2.1.2 Foot and Mouth Disease (FMD) Vaccines Consumption CAGR by Region
2.2 Foot and Mouth Disease (FMD) Vaccines Segment by Type
2.2.1 Emergency Vaccines
2.2.2 Conventional Vaccines
2.3 Foot and Mouth Disease (FMD) Vaccines Consumption by Type
2.3.1 Global Foot and Mouth Disease (FMD) Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Foot and Mouth Disease (FMD) Vaccines Sale Price by Type (2015-2020)
2.4 Foot and Mouth Disease (FMD) Vaccines Segment by Application
2.4.1 Cattle
2.4.2 Pig
2.4.3 Sheep & Goat
2.4.4 Others
2.5 Foot and Mouth Disease (FMD) Vaccines Consumption by Application
2.5.1 Global Foot and Mouth Disease (FMD) Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Foot and Mouth Disease (FMD) Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Foot and Mouth Disease (FMD) Vaccines Sale Price by Type (2015-2020)
3 Global Foot and Mouth Disease (FMD) Vaccines by Company
3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company
3.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Company (2018-2020)
3.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Company
3.2.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2018-2020)
3.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Sale Price by Company
3.4 Global Foot and Mouth Disease (FMD) Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Foot and Mouth Disease (FMD) Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Foot and Mouth Disease (FMD) Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Foot and Mouth Disease (FMD) Vaccines by Regions
4.1 Foot and Mouth Disease (FMD) Vaccines by Regions
4.2 Americas Foot and Mouth Disease (FMD) Vaccines Consumption Growth
4.3 APAC Foot and Mouth Disease (FMD) Vaccines Consumption Growth
4.4 Europe Foot and Mouth Disease (FMD) Vaccines Consumption Growth
4.5 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption Growth
5 Americas
5.1 Americas Foot and Mouth Disease (FMD) Vaccines Consumption by Countries
5.1.1 Americas Foot and Mouth Disease (FMD) Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Foot and Mouth Disease (FMD) Vaccines Value by Countries (2015-2020)
5.2 Americas Foot and Mouth Disease (FMD) Vaccines Consumption by Type
5.3 Americas Foot and Mouth Disease (FMD) Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Foot and Mouth Disease (FMD) Vaccines Consumption by Regions
6.1.1 APAC Foot and Mouth Disease (FMD) Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Foot and Mouth Disease (FMD) Vaccines Value by Regions (2015-2020)
6.2 APAC Foot and Mouth Disease (FMD) Vaccines Consumption by Type
6.3 APAC Foot and Mouth Disease (FMD) Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Foot and Mouth Disease (FMD) Vaccines by Countries
7.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Value by Countries (2015-2020)
7.2 Europe Foot and Mouth Disease (FMD) Vaccines Consumption by Type
7.3 Europe Foot and Mouth Disease (FMD) Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines by Countries
8.1.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption by Type
8.3 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Foot and Mouth Disease (FMD) Vaccines Distributors
10.3 Foot and Mouth Disease (FMD) Vaccines Customer
11 Global Foot and Mouth Disease (FMD) Vaccines Market Forecast
11.1 Global Foot and Mouth Disease (FMD) Vaccines Consumption Forecast (2021-2025)
11.2 Global Foot and Mouth Disease (FMD) Vaccines Forecast by Regions
11.2.1 Global Foot and Mouth Disease (FMD) Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Foot and Mouth Disease (FMD) Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Foot and Mouth Disease (FMD) Vaccines Forecast by Type
11.8 Global Foot and Mouth Disease (FMD) Vaccines Forecast by Application
12 Key Players Analysis
12.1 Jinyu Group
12.1.1 Company Information
12.1.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Jinyu Group Latest Developments
12.2 MSD Animal Health
12.2.1 Company Information
12.2.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.2.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 MSD Animal Health Latest Developments
12.3 Cavet Bio
12.3.1 Company Information
12.3.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.3.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Cavet Bio Latest Developments
12.4 Tecon Group
12.4.1 Company Information
12.4.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Tecon Group Latest Developments
12.5 CAHIC
12.5.1 Company Information
12.5.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 CAHIC Latest Developments
12.6 Indian Immunologicals
12.6.1 Company Information
12.6.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.6.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Indian Immunologicals Latest Developments
12.7 BIGVET Biotech
12.7.1 Company Information
12.7.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.7.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 BIGVET Biotech Latest Developments
12.8 Shen Lian
12.8.1 Company Information
12.8.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.8.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Shen Lian Latest Developments
12.9 Boehringer Ingelheim
12.9.1 Company Information
12.9.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Boehringer Ingelheim Latest Developments
12.10 Biogenesis Bagó
12.10.1 Company Information
12.10.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.10.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Biogenesis Bagó Latest Developments
12.11 Sanofi (Merial)
12.11.1 Company Information
12.11.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.11.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Sanofi (Merial) Latest Developments
12.12 BVI
12.12.1 Company Information
12.12.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.12.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 BVI Latest Developments
12.13 VETAL
12.13.1 Company Information
12.13.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.13.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 VETAL Latest Developments
12.14 CEVA
12.14.1 Company Information
12.14.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.14.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 CEVA Latest Developments
12.15 Brilliant Bio Pharma
12.15.1 Company Information
12.15.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.15.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Brilliant Bio Pharma Latest Developments
12.16 Bayer HealthCare
12.16.1 Company Information
12.16.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.16.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Bayer HealthCare Latest Developments
12.17 ME VAC
12.17.1 Company Information
12.17.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.17.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 ME VAC Latest Developments
12.18 VECOL
12.18.1 Company Information
12.18.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.18.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 VECOL Latest Developments
12.19 FGBI
12.19.1 Company Information
12.19.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.19.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 FGBI Latest Developments
12.20 LIMOR
12.20.1 Company Information
12.20.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.20.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 LIMOR Latest Developments
12.21 Agrovet
12.21.1 Company Information
12.21.2 Foot and Mouth Disease (FMD) Vaccines Product Offered
12.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Agrovet Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Foot and Mouth Disease (FMD) Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
